I have updated the spreadsheet to reflect recent announcements, like SOLID PI, and is available here:
Feel free to edit it, it's open to anyone for edition.
Feel free to edit it, it's open to anyone for edition.
-
-
I've added new machines to the Google Spreadsheet for NGS, with the Ion Torrent announcements, and more details on Reagents prices from PacBio, Illumina and SOLID.
There are still empty fields, like base price for an Illumina IIx and HiSeq2000, which are a mystery that cannot be Googled for.
-
After a bit of inquiring, I've added the price at 500k for both GAIIx and HiSeq2000 from Illumina. If anyone knows of a better estimate for it, feel free to update the spreadsheet:
Comment
-
I've tentatively added two rows for the technology average read error rate. Any suggestions on a comprehensive error study rather than relying on the initial papers for each technology?Comment
-
It would be great if people could reference the appropriate information source for these numbers.--
bioinfosmComment
-
Done! I've put the reference in for the rates I've quoted.Comment
-
CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).
Despite this, “CRISPR helped turn genome editing from a specialized technique into...07-31-2026, 11:01 AM -
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...07-20-2026, 11:48 AM -
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...07-09-2026, 11:10 AM
Comment